Although both parameters (possibly GDF-15 superior to FGF-21) are considered capable of distinguishing patients with mitochondrial diseases from those without [36], serum concentrations of both molecules are likely to be significantly affected by vascular and metabolic diseases. Here, GDF15 is linked to metabolic disease.